Insulin detemir treatment in diabetic cats in a practice setting
- PMID: 24938314
- PMCID: PMC10816420
- DOI: 10.1177/1098612X14538642
Insulin detemir treatment in diabetic cats in a practice setting
Abstract
Insulin detemir is a long-acting insulin analogue and may represent a valuable treatment option for diabetic cats. So far, only one study addressing detemir treatment of diabetic cats has been published, and this was based on an intensive blood glucose monitoring protocol. The aim of the current, retrospective study was to evaluate the effect of detemir therapy in diabetic cats in a general clinical setting. Fourteen diabetic cats with a follow-up period of at least 3 months were included. Data were collected from medical records at the University Hospital for Companion Animals, University of Copenhagen, Denmark. Thirteen of 14 cats achieved moderate or excellent control of clinical symptoms within the initial 3 months of detemir therapy, including five cats previously treated unsuccessfully with other types of insulin. Clinical improvements were noted after 1 month of therapy and continued over time. Three cats achieved remission within the initial 3 months and none experienced a diabetic relapse during the study period. One cat achieved remission after 13 months of therapy. Improvements in clinical symptoms were markedly better than indicated by blood glucose and serum fructosamine concentrations. The safety of detemir was very high, with only two reported episodes of clinical hypoglycaemia, neither of which required veterinary attention. Based on these results detemir can be recommended for the treatment of diabetic cats, including cats previously treated unsuccessfully with other types of insulin.
© ISFM and AAFP 2014.
Conflict of interest statement
The authors do not have any potential conflicts of interest to declare.
Figures
References
-
- Baral RM, Rand JS, Catt MJ, et al. Prevalence of feline diabetes mellitus in a feline private practice. J Vet Intern Med 2003; 17: 433–434.
-
- Eldor R, Raz I. Lipotoxicity versus adipotoxicity – the deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes. Diabetes Res Clin Pract 2006; 74S: S3–S8.
-
- American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Committee report. Diabetes Care 1997; 20: 1183–1197. - PubMed
-
- Marshall RD, Rand JS, Morton JM. Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats. J Vet Pharmacol Ther 2008; 31: 205–212. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
